Novo Nordisk Partners with WeightWatchers to Expand Access to Wegovy® with New Nationwide Pricing Initiative

Novo Nordisk continues expansion of patient access to Wegovy® (semaglutide) injection 2.4 mg through a new collaboration with WeightWatchers...

June 27, 2025 | Friday | News
Nu Skin Revamps ageLOC® Tru Face® Line with Refillable, Eco-Conscious Packaging

Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness company, is breathing new life into its iconic ageLOC® Tru Face® line with a r...

June 26, 2025 | Thursday | News
Nutriband and Kindeva Complete Commercial Manufacturing Scale-Up for AVERSA™ Fentanyl, Advancing World’s First Abuse-Deterrent Opioid Patch

Nutriband Inc.  a company engaged in the development of prescription transdermal pharmaceutical products, announced that it has completed commercial...

June 24, 2025 | Tuesday | News
Lilly’s Once-Weekly Efsitora Matches Daily Insulin in Phase 3 Trials, Global Filing Planned by Year-End

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with...

June 23, 2025 | Monday | Reports
PharmaJet and Immuno Cure Partner to Advance Needle-Free HIV Therapeutic DNA Vaccine with Tropis® ID System

Agreement builds on PharmaJet’s strategy to be the best-in-class delivery system for novel DNA- and RNA-based vaccines and immunotherapies usin...

June 20, 2025 | Friday | News
NeuralCure AI Launches First Diagnostic & Digital Twin OS to Power Patient-Led Healthcare Revolution

NeuralCure AI  announced the official launch of its groundbreaking Diagnostic & Digital Twin Operating System, the first infrastructure platform...

June 20, 2025 | Friday | News
Draig Therapeutics Launches with $140M to Advance Novel Neuropsychiatric Treatments

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of ...

June 19, 2025 | Thursday | News
Incannex and Mind Medicine Australia Launch Joint Venture to Open Psychedelic Therapies Clinic in Melbourne

Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combi...

June 18, 2025 | Wednesday | News
Integrated DNA Technologies Expands Infectious Disease Portfolio With Advanced Solutions for Global Research and Surveillance

Integrated DNA Technologies (IDT), a global genomics leader, is expanding its infectious disease portfolio with new solutions to enhance worldwide research...

June 17, 2025 | Tuesday | News
University of Oxford and ReciBioPharm Expand Collaboration to Manufacture Malaria Vaccine Candidates

  Expands the collaboration to manufacture two malaria vaccine candidates (R78C and RH5.1) for Phase 1/2 clinical trials. Delivers the sixth m...

June 17, 2025 | Tuesday | News
diaMentis Joins Dassault Systèmes’ 3DEXPERIENCE Lab to Advance FDA-Recognised Mental Health Diagnostic Technology

diaMentis, a company developing an innovative diagnostic support technology in mental health, recognized by the U.S. Food and Drug Administration (FDA) a...

June 13, 2025 | Friday | News
Chiesi Group and Key2Brain Expand Collaboration to Advance BBB-Crossing Therapies for Ultra-Rare Lysosomal Storage Disorders

Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disor...

June 12, 2025 | Thursday | News
Angelini Ventures Invests in Elkedonia to Advance First-in-Class Neuroplastogen for Treatment-Resistant Depression

Investment supports the development of first-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existi...

June 12, 2025 | Thursday | News
BioAegis Advances Phase 2 Study of rhu-pGSN to Combat Decompression Sickness in SCUBA Divers

Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for th...

June 12, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close